Where does Abcuro's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Abcuro's 5 recorded funding rounds.

Premier Alternatives

Abcuro

Drug Discovery · Newton, MA · Founded 2015 · Privately Held (backing)

Developer of immunomodulatory therapeutics designed for treating both autoimmunity and cancer. Abcuro is based in Newton, MA and was founded in 2015. It was valued at $700 million at its later-stage round in Feb 2025, the last priced event on record. It has raised $407 million across 5 recorded rounds; the latest was a $200 million Series C in Feb 2025.

PMV mark · valuation

$700.0M

Oct 2026

Priced at

its later-stage round

Feb 2025

Total raised

$407.3M

Last round

Later Stage VC (Series C)

Feb 2025

Cap table — not yet on record

Abcuro's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Abcuro with a free account

·The complete investor list: 20 names
·Watch Abcuro: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Abcuro

Where does Abcuro's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Abcuro's 5 recorded funding rounds.